Skip to main content
SpringerLink
Log in

Gutartige Brusterkrankungen

  • Chapter
Gynäkologische Endokrinologie

Zusammenfassung

Die klinische Diagnose „Mastopathie“ umfaßt gutartige, mehr oder weniger diffuse Veränderungen der weiblichen Brustdrüse (Verdichtung, Knoten) und damit einhergehende Beschwerden (Mastodynie). Pathologisch-anatomisch findet sich bei klinischer Mastopathie ein buntes Bild histologischer Veränderungen. Neue pathologisch-anatomische Einteilungen differenzieren in erster Linie nach dem Entartungsrisiko.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • D’Agata R, Aliffi A, Maugeri G, Mongioi A, Vicari E, Gulizia S (1982) Dynamics of Prl release in galactorrhoeic normoprolactinaemic women. Acta Endocrinol 101: 1–4

    PubMed  Google Scholar 

  • Ahumada JC, del Castillo EB (1932) Amenorrhea y galactorrhea. Bol Soc Obstet Ginec of Buenos Aires 11: 64–67

    Google Scholar 

  • Aksu MF, Tzingounis VA, Greenblatt RB (1978) Treatment of benign breast disease with danazol: a follow-up report. J Reprod Med 21: 181–184

    PubMed  CAS  Google Scholar 

  • Andersen AN, Larsen JF, Steenstrup OR, Svendstrup B, Nielsen J (1977) Effect of bromocriptine on the premenstrual syndrome. A double-blind clinical trial. Br J Obstet Gynaecol 84: 370–374

    Google Scholar 

  • Arabin B, v. Fournier D, Kubli F, Müller A, Weber E (1985) Probleme und Grenzen der mammographischen Karzinomdiagnostik: Vergleich der präoperativen radiologischen Diagnose mit dem histologischen Befund bei 335 Patientinnen mit subkutaner Mastektomie. Geburtshilfe Frauenheilkd 45: 595–603

    Article  PubMed  CAS  Google Scholar 

  • Argonz J, del Castillo EB (1953) A syndrome characterized by estrogenic insufficiency, galactorrhea, and decreased urinary gonadotropin. J Clin Endocrinol 13: 79

    Article  CAS  Google Scholar 

  • Ariel IM (1973) Enovid therapy (norethynodrel with mestranol) for fibrocystic disease. Am J Obstet Gynecol 117: 453–459

    PubMed  CAS  Google Scholar 

  • Asch RH (1977) The use of an impeded androgen–danazol–in the management of benign breast disorders. Am J Obstet Gynecol 127: 130–134

    PubMed  CAS  Google Scholar 

  • Ashikari R, Huvos GH, Snyder RE, Lucas JC, Hutter RVP, McDivitt RW, Schottenfeld D (1974) A clinicopathologic study of atypical lesions of the breast. Cancer 33: 310–317

    Article  PubMed  CAS  Google Scholar 

  • Atkins HJB (1949) The effect of endocrines on fibroadenosis. Br Med J: 750–752

    Google Scholar 

  • Ayers JWT, Gidwani GP (1983) The „luteal breast“: hormonal and sonographic investigation of benign breast disease in patients with cyclic mastalgia. Fertil Steril 40: 779–784

    PubMed  CAS  Google Scholar 

  • Azzopardi JG (1979) Problems in breast pathology. Saunders, London

    Google Scholar 

  • Bässler R, Schulze G, Schriever D (1970) Histochemische Untersuchungen am Bindegewebe der hormonal stimulierten Mamma. Beitr pathol Anat 140: 212–236

    PubMed  Google Scholar 

  • Bässler R (1978) Pathologie der Brustdrüse. In: Dörr W, Seifert G, Uehlinger E (Hrsg) Spezielle pathologische Anatomie, Bd 11. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Bauer M, v. Fournier D, Späh U, Kubli F, Jansa J (1982) Behandlungsergebnisse bei der Mastopathie. In: Frischbier HJ (Hrsg) Die Erkrankungen der weiblichen Brustdrüse. Thieme, Stuttgart

    Google Scholar 

  • Berta L, Frairia R, Bumma C, Navello C, Mossetti C, Rovero E, Gaidano G (1983) Hormonal pattern and sex hormone binding globulin in plasma of women with cystic breast disease. In: Angeli A, Bradlow HL, Dogliotti L (eds) Endocrinology of cystic breast disease. Raven, New York, pp 123–126

    Google Scholar 

  • Bischoff J, Rebhan EM, Prestele H, Becker H (1980) Serum-Prolaktin und Anamnesevergleich bei Mammazysten und zystischer Mastopathie. Geburtshilfe Frauenheilkd 40: 65–71

    Article  PubMed  CAS  Google Scholar 

  • Bischoff J, Mulz D, Knüpfer A, Becker H (1981) Therapie von Mammazysten mit 2-alpha-Bromergokriptin. Geburtshilfe Frauenheilkd 41: 635–637

    Article  PubMed  CAS  Google Scholar 

  • Blichert-Toft M, Nyboe Andersen A, Henriksen OB, Mygind T (1979) Treatment of mastalgia with bromocriptine: a double-blind cross-over study. Br Med J: 237

    Google Scholar 

  • De Boever J, Verheugen C, van Maele G, Vandekerckhove D (1983) Steroid concentrations in serum glandular breast tissue, and breast cyst fluid of control and progesterone-treated patients. In: Angeli A, Bradlow HL, Dogliotti L (eds) Endocrinology of cystic breast disease. Raven, New York, pp 93–99

    Google Scholar 

  • Bohnet HG (1981) Prolaktin and seine Bedeutung für die Frau. In: Schirren C, Semm K (Hrsg) Fortschritte der Fertilitätsforschung 9. Grosse, Berlin

    Google Scholar 

  • Bohnet HG, Gómez F, Friesen HG (1977) Prolactin and estrogen binding sites in the mammary gland of the lactating and non-lactating rat. Endocrinology 101: 1111–1121

    Article  PubMed  CAS  Google Scholar 

  • Brennan MJ, Bulbrook RD, Deshpande N, Wang DY (1973) Urinary and plasma androgens in benign breast disease. Lancet I: 1076–1079

    Google Scholar 

  • Bruning PF, Bonfrèr JMG, Bobrow L, de Jong-Bakker M, Hart AAM, Misdorp W (1984) Plasma hormones in premenopausal women with benign breast disease. In: International Congress, endocrinology of the breast, Torino, Italy. NY Acad Sci (Abstract 102 )

    Google Scholar 

  • Carlström K, Döberl A, Gershagen S, Rannevik G (1984) Peripheral levels of androgens and of some steroid sensitive plasma proteins in patients with fibrocystic breast disease. In: International Congress, endocrinology of the breast, Torino, Italy. NY Acad Sci (Abstract 103 )

    Google Scholar 

  • Chiari J (1852) Anomalien der Größe. In: Klinik der Geburtshilfe and Gynäkologie. Enke, Erlangen

    Google Scholar 

  • Cole EN, Sellwood RA, England PC, Griffiths K (1977) Serum prolactin concentrations in benign breast disease throughout the menstrual cycle. Eur J Cancer 13: 597–603

    PubMed  CAS  Google Scholar 

  • Colin C, Gaspard U, Lambotte R (1978) Relationship of mastodynia with its endocrine environment and treatment in a double blind trial with lynestrenol. Arch Gynäkol 225: 7–13

    Article  PubMed  CAS  Google Scholar 

  • Davajan V, Kletzky 0, March ChM, Roy S, Mishell DR Jr (1978) The significance of galactorrhea in patients with normal menses, oligomenorrhea, and secondary amenorrhea. Am J Obstet Gynecol 130: 894–904

    PubMed  CAS  Google Scholar 

  • Dhont M, Delbeke L, VanEyck J, Voorhoof L (1979) Danazol treatment of chronic cystic mastopathy; a clinical and hormonal evaluation. Postgrad Med J 55: 66–70

    PubMed  Google Scholar 

  • Durning P, Sellwood RA (1982) Bromocriptine in severe cyclical breast pain. Br J Surg 69: 248–249

    Article  PubMed  CAS  Google Scholar 

  • Dupont WD, Page DL (1985) Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312: 146–151

    Article  PubMed  CAS  Google Scholar 

  • England PC, Skinner LG, Cottrell KM, Sellwood RA (1974) Serum oestradiol-17ß in women with benign and malignant breast disease. Br J Cancer 30: 571–576

    Article  PubMed  CAS  Google Scholar 

  • Ernster VL (1981) The epidemiology of benign breast disease. Epidemiol Rev 3: 184–202

    PubMed  CAS  Google Scholar 

  • Fentiman IS, Caleffi M, Brame K, Chaudary MA, Hayward JL (1986) Double-blind controlled trial of tamoxifen therapy for mastalgia. Lancet I: 287–288

    Google Scholar 

  • Ferenczy A (1979) Proliferation kinetics of human endometrium during the normal menstrual cycle. Am J Obstet Gynecol 133: 859–867

    PubMed  CAS  Google Scholar 

  • Ferguson DJP, Anderson TJ (1981) Morphological evaluation of cell turnover in relation to the menstrual cycle in the „resting“ human breast. Br J Cancer 44: 177–181

    Article  PubMed  CAS  Google Scholar 

  • Forbes AP, Hennemann PH, Griswold GC, Albright F (1954) Syndrome characterized by galactorrhea, and low urinary FSH: Comparison with acromegaly and normal lactation. J Clin Endocrinol 14: 265

    Google Scholar 

  • von Fournier D, Kubli F, Junkermann H, Bauer M, Legler U, Arabin B, Müller A (1984) Medikamentöse and operative Therapie der Mastopathie in Abhängigkeit vom Entartungsrisiko. Frauenarzt 4: 27–39

    Google Scholar 

  • Frantz VK, Pickren JW, Melcher GW, Auchincloss H jr (1951) Incidence of chronic cystic disease in so-called „normal breasts“. A study based on 225 postmortem examinations. Cancer 4: 762–783

    Article  PubMed  CAS  Google Scholar 

  • Frommel R (1882) Über puerperale Atrophie des Uterus. Z Geburtshilfe Gynakol 7: 305–318

    Google Scholar 

  • Gangemi M, Velasco M, Graziottin A, Licori D, Marchesoni D (1981) Bromoergocriptin therapy in eumenorrhoic patients presenting galactorrhea. Clin Exp Obstet Gynacol 2: 79–82

    Google Scholar 

  • Geschickter ChF (1948) Diseases of the breast; diagnosis, pathology, treatment, 2nd edn. Lippincott, Philadelphia

    Google Scholar 

  • Geschickter ChF, Hartman CG (1959) Mammary response to prolonged estrogenic stimulation in the monkey. Cancer 12: 767–781

    Article  PubMed  CAS  Google Scholar 

  • Göbel R (1984) Results of the clinical evaluation of danazol in benign breast disease compared with local treatment, gestagens and bromocriptine. In: Baum M, George WD, Hughes LE (eds) Benign breast disease. The Royal Society of Medicine, London 76: 115–120

    Google Scholar 

  • Gorins A, Cordray JP (1984) Hormonal profile of benign breast disease and premenstrual mastodynia. Eur J Gynaecol Oncol 1: 1–10

    Google Scholar 

  • Grattarola R (1978) Anovulation and increased androgenic activity as breast cancer risk in women with fibrocystic disease of the breast. Cancer Res 38: 3051–3054

    Google Scholar 

  • Graziottin A, Sopracordevole F, Velasco M, Grella PV (1984) Plasma prolactin in women with mastodynia. Clin Exp Obstet Gynecol 3: 113–115

    Google Scholar 

  • Greenblatt B, Ben-Nun I (1980) Danazol in the treat- ment of mammary dysplasia. Drugs 19: 349–355

    Article  PubMed  CAS  Google Scholar 

  • Haagensen CD (1971) Diseases of the breast, 2nd edn. Saunders, Philadelphia

    Google Scholar 

  • Haagensen CD, Bodian C, Haagensen DE jr (1981) Breast carcinoma: risk and detection. Saunders, Philadelphia

    Google Scholar 

  • Hammond GL, Nisker JA, Jones LA, Siiteri PK (1980) Estimation of the percentage of free steroid in undiluted serum by centrifugal ultrafiltration-dialysis. J Biol Chem 11: 5023–5026

    Google Scholar 

  • Jones JR, Gentile GP (1975) Incidence of galactorrhea in ovulatory and anovulatory females. Obstet Gynecol 45: 13–14

    PubMed  CAS  Google Scholar 

  • Kaiser R (1969) Zur Ätiologie und Prophylaxe des Endometriumkarzinoms. Geburtshilfe Frauenheilkd 29: 431

    PubMed  CAS  Google Scholar 

  • Kleinberg DL, Noel GL, Frantz AG (1977) Galactorrhea: a study of 235 cases, including 48 with pituitary tumors. N Engl J Med 296: 589–600

    Article  PubMed  CAS  Google Scholar 

  • Kolodny RC, Jacobs LS, Daughaday WH (1972) Mammary stimulation causes prolactin secretion in non-lactating women. Nature 238: 284–286

    Article  PubMed  CAS  Google Scholar 

  • Kramer WM, Rush RF (1973) Mammary duct proliferation in the elderly. Cancer 31: 130–137

    Article  PubMed  CAS  Google Scholar 

  • Kubista E, Müller G, Spona J (1984) Treatment of painful mastopathy. A prospective randomized trial. In: International congress, endocrinology of the breast. Torino, Italy. NY Acad Sci (Abstract 120 )

    Google Scholar 

  • Kumar S, Mansel RE, Hughes LE, Woodhead JS, Edwards CA, Scanlon MF, Newcombe RG (1984) Prolactine response to thyrotropin-releasing hormone stimulation and dopaminergic inhibition in benign breast disease. Cancer 53: 1311–1315

    Article  PubMed  CAS  Google Scholar 

  • Lang WR, Renwick S, Johnson L, Wyse E (1972) Benign mammary dysplasia. Med J Aust 2: 147–149

    PubMed  CAS  Google Scholar 

  • Lauersen NH, Wilson KH (1976) The effect of danazol in the treatment of chronic cystic mastitis. Ob-stet Gynecol 48: 93–98

    CAS  Google Scholar 

  • Leucht W, Rabe D, Boos R, Humbert KD, v. Fournier D, Schmidt W (1984) Stellenwert der hochauflösenden Real-Time-Sonographie beim Mammakarzinom. Geburtshilfe Frauenheilkd 44: 557–562

    Article  PubMed  CAS  Google Scholar 

  • LiVolsi VA, Stadel BV, Kelsey JL, Holford TR, White C (1978) Fibrocystic breast disease in oral-contraceptive users. A histopathological evaluation of epithelial atypia. N Engl J Med 299: 381–385

    Google Scholar 

  • Mancini AM, Aparicio NJ, Vargas CA, Debeljuk L, Guitelman A (1978) Serum levels of prolactin under basal conditions and after administration of sulpiride in normal and galactorrheic women. Fertil Steril 29: 459–461

    PubMed  CAS  Google Scholar 

  • Mansel RE, Preece PE, Hughes LE (1980) Treatment of cyclical breast pain with bromocriptine. Scott Med J 25: 65–70

    Google Scholar 

  • Mansel RE, Wisbey JR, Hughes LE (1982) Controlled trial of the antigonadotropin danazol in painful nodular benign breast disease. Lancet 1: 928–930

    Article  PubMed  CAS  Google Scholar 

  • Martin PM, Kuttenn F, Serment H, Mauvais-Jarvis P (1978) Studies on clinical hormonal and pathological correlations in breast fibroadenomas. J Steroid Biochem 9: 1251–1255

    Article  PubMed  CAS  Google Scholar 

  • Masters JRW, Drife JO, Scarisbrick JJ (1977) Cyclic variation of DNA synthesis in human breast epithelium. JNCI 58: 1263–1265

    PubMed  CAS  Google Scholar 

  • Mauvais-Jarvis P, Kuttenn F, Ohlgiesser C (1974) Résultats du traitement des mastodynies et des mastopathies par la progestérone percutanée. Nouv Presse Mèd 16: 1027–1028

    Google Scholar 

  • Minton JP, Abou-Issa H, Reiches N, Roseman JM (1981) Clinical and biochemical studies on methylxanthine-related fibrocystic breast disease. Surgery 90: 299–304

    PubMed  CAS  Google Scholar 

  • Moore JW, Clark GMG, Bulbrook RD, Hayward JL, Murai JT, Hammond GL, Siiteri PK (1982) Serum concentrations of total and non-protein-bound oestradiol in patients with breast cancer and in normal controls. Int J Cancer 29: 17–21

    Article  PubMed  CAS  Google Scholar 

  • Mühlenstedt D, Böttcher HD, Osmers F (1983) Endokrinologisch-radiologische Aspekte der Galaktorrhö. Medwelt 34: 302–307

    Google Scholar 

  • Noel GL, Suh HK, Frantz AG (1974) Prolactin release during nursing and breast stimulation in postpartum and nonpostpartum subjects. J Clin Endocrinol Metab 38: 413–423

    Article  PubMed  CAS  Google Scholar 

  • Nordquist S (1970) The synthesis of DNA and RNA in normal human endometrium in shortterm incubation in vitro and its response to oestradiol and progesterone. J Endocrinol 48: 17–28

    Article  Google Scholar 

  • Nyirjesy I (1968) Galactorrhea without amenorrhea. Obstet Gynecol 32: 52–57

    PubMed  CAS  Google Scholar 

  • Ouimet-Oliva D, van Campenhout J, Hébert G, Ladouceur J (1981) Effect of danazol on the radiographic density of breast parenchyma. J Can Assoc Radiol 32: 159–161

    PubMed  CAS  Google Scholar 

  • Petrakis NL, Mason L, Lee R, Sugimoto B, Pawson S, Catchpool F (1975) Association of race, age, menopausal status, and cerumen type with breast fluid secretion in nonlactating women, as determined by nipple aspiration. JNNCI 54: 829–833

    CAS  Google Scholar 

  • Peters F, Pickardt CR, Zimmermann G, Breckwoldt M (1981) PRL, TSH, and thyroid hormones in benign breast diseases. Klin Wochenschr 59: 403–407

    Google Scholar 

  • Peters F, Pickardt CR, Breckwoldt M (1983) Hormonal status of women with benign cystic breast disease: clinical implications. In: Angeli A, Brad-low HL, Dogliotti L (eds) Endocrinology of cystic breast disease. Raven, New York, pp 113–122

    Google Scholar 

  • Preece PE, Richards AR, Owen GM, Hughes LE (1975) Mastalgia and total body water. Br Med J 4: 498–500

    Article  PubMed  CAS  Google Scholar 

  • Preece PE, Baum M, Mansel RE, Webster DJT, Fora RW, Gravelle IH, Hughes LE (1982) Importance of mastalgia in operable breast cancer. Br Med J 284: 1299–1300

    Article  CAS  Google Scholar 

  • Rannevik G, Döberl A, Gershagen S, Rasmussen Th, Tobiassen T (1983) Elevated serum concentrations of sex hormone binding globulin in fibrocystic breast disease. In: Angeli A, Bradlow HL, Dogliotti L (eds) Endocrinology of cystic breast disease. Raven, New York, pp 127–134

    Google Scholar 

  • Rasmussen Th, Döberl A, Rannevik G, Tobiassen T (1984) The Hjerring project on fibrocystic breast disease. In: Baum M, George WD, Hughes LE (eds) Benign breast disease. The Royal Society of Medicine, London. 76: 135–139

    Google Scholar 

  • Reed MJ (1983) Plasma levels of estrone, estrone sulfate, and estradiol and the percentage of unbound estradiol in postmenopausal women with and without breast disease. Cancer Res 43: 3940–3942

    PubMed  CAS  Google Scholar 

  • Ricciardi I, Ianniruberto A (1979) Tamoxifen-Induced Regression of Benign Breast Lesions. Obstet Gynecol 54: 80–84

    Article  PubMed  CAS  Google Scholar 

  • Schulz KD, Del Pozo E, Lose KH, Künzig HJ, Geiger W (1975) Successful treatment of mastodynia with the prolactin inhibitor bromocryptine (CB 154). Arch Gynäkol 220: 83–87

    Article  PubMed  CAS  Google Scholar 

  • Secreto G, Recchione C, Fariselli G, Di Pietro S (1984) High testosterone and low progesterone circulating levels in premenopausal patients with hyperplasia and cancer of the breast. Cancer Res 44: 841–844

    PubMed  CAS  Google Scholar 

  • Sitruk-Ware LR, Sterkers N, Mowszowicz I, Mauvais-Jarvis P (1977) Inadequate corpus luteal function in women with benign breast diseases. J Clin Endocrinol Metab 44: 771–774

    Article  PubMed  CAS  Google Scholar 

  • Sundaram GS, London R, Margolis S, Wenk R, Lustgarten J, Nair PP, Goldstein P (1981) Serum hormones and lipoproteins in benign breast disease. Cancer Res 41: 3814–3816

    PubMed  CAS  Google Scholar 

  • Tabâr L, Dean PB (1982) Mammographic parenchymal patterns. Risk indicator for breast cancer? JA-MA 247: 185–189

    Article  Google Scholar 

  • Tarquini B, Benvenuti M, Legnaioli M, Bazzani M, Cagnoni M, Halberg F (1981) Mammary cancer risk: circulating TSH and prolactin fibrocystic breast disease in chronoepidemiologic perspective. Cancer Detec Prey 4: 525–534

    CAS  Google Scholar 

  • Teubner J, Junkermann H, van Kaick G, Pickenhan L, Wesch H, Eggert-Kruse W, v. Fournier D, Kubli F (1984) Diagnostische Wertigkeit der Mammasonographie bei Anwendung eines linearen 5 MHZ-Realtine-Scanners (LS 3000, Fa. Picker). Ergebnisse einer prospektiven Studie. In: Lutz H, Reichel L (Hrsg) Ultraschalldiagnostik 83. Thieme, Stuttgart, S 89–92

    Google Scholar 

  • Thomas BS, Kirby P, Symes EK, Wang DY (1976) Plasma dehydroepiandrosterone concentration in normal women and in patients with benign and malignant breast disease. Eur J Cancer 12: 405–409

    PubMed  CAS  Google Scholar 

  • Vetter L, Kraner F, Wyss H (1974) Galactorrhea. Arch Gynecol 216: 81–90

    CAS  Google Scholar 

  • Walsh PV, Morris K, McDicken IW, Whitehouse GN, George WD (1984) Luteal phase function and benign breast disease. In: Baum M, George WD, Hughes LE (eds) Benign breast disease. The Royal Society of Medicine, London, pp 53–62

    Google Scholar 

  • Wang DY, Hayward JL, Bulbrook RD (1966) Testosterone levels in the plasma of normal women and patients with benign breast disease or with breast cancer. Eur J Cancer 2: 373–376

    PubMed  CAS  Google Scholar 

  • Watt-Boolsen S, Andersen AN, Blichert-Toft M (1981) Serum prolactin and oestradiol levels in women with cyclical mastalgia. Horm Metab Res 13: 700–702

    Article  PubMed  CAS  Google Scholar 

  • Wolfe JN (1976) Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer 37: 2486–2492

    Article  PubMed  CAS  Google Scholar 

  • Wynder EL, Hill P, Laakso K, Littner R, Kettunen K (1981) Breast Secretion in Finnish women: a metabolic epidemiologic study. Cancer 47: 1444–1450

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. H. Junkermann
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Junkermann, H. (1987). Gutartige Brusterkrankungen. In: Gynäkologische Endokrinologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71568-6_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-71568-6_17

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-71569-3

  • Online ISBN: 978-3-642-71568-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation